258
Views
0
CrossRef citations to date
0
Altmetric
Methodology

Characterization and Development of a Luminex®-Based Assay for The Detection of Human IL-23

, , , &
Pages 1561-1572 | Published online: 20 Aug 2010

Bibliography

  • Oppmann B , LesleyR, BlomBet al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity13, 715–725 (2000).
  • Parham C , ChiricaM, TimansJet al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699–5708 (2002).
  • Kim HR , ChoML, KimKWet al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-κB- and p38 MAPK-dependent signalling pathways. Rheumatology46, 57–64 (2007).
  • Langowski JL , ZhangX, WuLet al. IL-23 promotes tumour incidence and growth. Nature442, 461–465 (2006).
  • Iwakura Y , IshigameH. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218–1222 (2006).
  • Stritesky GL , YehN, KaplanMH. IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol. 181, 5948–5955 (2008).
  • Kolls JK , LindenA. Interleukin-17 family members and inflammation. Immunity21, 467–476 (2004).
  • Kikly K , LiuL, NaS, SedgwickJD. The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18, 670–675 (2006).
  • Kageyama Y , IchikawaT, NagafusaT, TorikaiE, ShimazuM, NaganoA. Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 α in patients with rheumatoid arthritis. Rheumatol. Int. 28, 137–143 (2007).
  • Yago T , NankeY, KawamotoMet al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res. Ther. 9, R96 (2007).
  • Cheng F , GuoZ, XuH, YanD, LiQ. Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 68, 604–606 (2009).
  • Gu Y , ZhangJ, PengJ, HuX, XuC. Elevated expression of IL-12 and IL-23 in patients with aplastic anemia. Int. J. Lab. Hematol. 31, 207–214 (2009).
  • Wong CK , LitLC, TamLS, LiEK, WongPT, LamCW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127, 385–393 (2008).
  • Samineni S , ParvataneniS, KellyC, GangurV, KarmausW, BrooksK. Optimization, comparison, and application of colorimetric vs. chemiluminescence based indirect sandwich ELISA for measurement of human IL-23. J. Immunoassay Immunochem. 27, 183–193 (2006).
  • Vignali DA . Multiplexed particle-based flow cytometric assays. J. Immunol. Methods243, 243–255 (2000).
  • Carson RT , VignaliDA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods227, 41–52 (1999).
  • Lee JW , DevanarayanV, BarrettYCet al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23, 312–328 (2006).
  • Pickering JW , MartinsTB, SchroderMC, HillHR. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b. Clin. Diagn. Lab. Immunol. 9, 872–876 (2002).
  • Oliver KG , KettmanJR, FultonRJ. Multiplexed analysis of human cytokines by use of the FlowMetrix system. Clin. Chem. 44, 2057–2060 (1998).
  • de Jager W , RijkersGT. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods38, 294–303 (2006).
  • Elshal MF , McCoyJP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods38, 317–323 (2006).
  • Kellar KL , IannoneMA. Multiplexed microsphere-based flow cytometric assays. Exp. Hematol. 30, 1227–1237 (2002).
  • Leng SX , McElhaneyJE, WalstonJD, XieD, FedarkoNS, KuchelGA. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. 63, 879–884 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.